ESKAPEing the labyrinth of antibacterial discovery
AstraZeneca (United Kingdom) · Novartis-MIT Center for Continuous Manufacturing
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
608
total citations
- FWCI
- 17.64
- Percentile
- 100%
- References
- 67
Citations per year
Authors
5Topics & keywords
Topics
Keywords
- Acinetobacter baumannii
- Antibiotic resistance
- Pseudomonas aeruginosa
- Drug discovery
- Enterococcus faecium
- Antimicrobial
- Antibiotics
- Biology
UN Sustainable Development Goals
- Zero hunger
No related works found for this paper.